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INTRODUCTION
The habit of chewing khat by the inhabitants of
Eastern Africa and Arabian peninsula has a long history.
Reference to its use and effects are found in old Arabian
literature and in the account of Carten Niebuhrat, an
eighteenth century traveller(1). Khat refers to the young
leaves and shoots of the plant Catha edulis (a species of the
Celestracecae family), a flowering evergreen tree or shrub
native to regions of eastern Africa and southern Arabia. It
has various local names such as qat in Yemen, eschat in
Ethiopia and miraa in Kenya. The leaves and shoots are
chewed and the juice swallowed which induces a
stimulatory and euphorogenic effect in the user. In many
societies, khat use has a traditional and culture role in
social life, and is used to ward off fatigue and stay alert,
similar to the use of cocoa leaves by the inhabitants of
Central and parts of South America. For over a century,
efforts have been made to isolate the key constituent of
khat responsible for its effects. This paper reviews the
effect of khat and current understanding of the mechanism
of action on the central nervous system (CNS) of its active
ingredient, cathinone.
EFFECTS OF KHAT
Khat has been described as a natural amphetamine
because its effects are similar to those produced by other
known psychostimulants such as amphetamine and its
congeners. Alles, Fairchild and Jensen(2) and Hughes(3),
after self-consumption of a portion of khat, reported that
the effects were similar to a low dose of amphetamine.
Like amphetamine, khat, has both peripheral and central
nervous system effects. The peripheral effects are mainly
sympathomimetic: increase in respiration, body
temperature, blood pressure, heart rate and mydriasis. The
central nervous system effects are euphoria, alertness, and
feeling of well being. In addition, there is insomnia,
anorexia, and at high doses, hyperactivity and excessive
talking. Psychiatric manifestations such as manic-like
behaviour(4) or schizophreniform psychosis(5) or
paranoia(6) can occur as a consequence of khat intoxication
and are similar to those reported with amphetamine
intoxication.
The use of khat often starts at a young age and can
develop into a compulsive daily habit lasting a lifetime. It
is estimated that there are five to ten million regular khat
users(7). The medical and socio-economic impact of khat
use on society generates regular, at times heated, debate on
whether khat should be considered a drug of abuse and be
banned or it should be looked upon as an innocuous
stimulant like caffeine conducive to social interaction.
The stimulating and euphoric effect of khat can provide a
strong inducement for the user to obtain the daily supply
and to have long khat chewing periods, especially as
tolerance develops with regular use. This strongly suggests
development of psychic or physical dependence or both in
the user. The World Health Organisation report on khat
concluded that khat use may give rise to moderate
dependence(8). As the withdrawal signs are minor -
lethargy, mild depression, nightmares, and slight tremor(9)-
physical dependence is not considered to be a major factor
though there appears to be a strong psychic dependency
component.
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cathedulins group, nearly 20 others compounds have been
isolated from khat such as tannins (7-14%), vitamin C
(150 mg/100 mg) and trace amounts of thiamine, niacin,
riboflavin and carotene.
CATHINONE EFFECTS
To determine whether cathinone is responsible for the
khat effects, several studies were undertaken. Wilder et
al(15) compared the effect of fresh and alkaloid-free
leaves in six drug naive volunteers. A single dose of khat
resulted in plasma cathinone reaching a concentration of
127±53 ng/ml 127±30 min after ingestion of fresh leaves.
The Addiction Research Centre Inventory scale, the motor
stimulation scale, and the amphetamine-like effect scale
were all significant compared to the effect after ingestion
of alkaloid-free leaves. The stimulatory effect observed
with this dose of khat was similar to a cathinone dose of 0.5
mg/kg body weight. In another clinical experiment, khat
effects were assessed in six healthy volunteers given,
orally, cathinone corresponding to 100 gm of khat leaves
of average cathinone content(16). Evaluation using the
questionnaires of the Addiction Research Centre Inventory
showed a significant psychostimulant and euphorogenic
effect and an increase in blood pressure and heart rate.
These changes were coincident with the presence of
cathinone (half-life of approximately 1.5 hr) in blood
plasma. These studies supported the view that cathinone
was the main active ingredient of khat and primarily
responsible for its psychostimulatory effect.
Although the effects observed in humans after khat
consumption appear to be explained satisfactorily by the
action of cathinone, there remained the possibility that
other alkaloids could contribute to the khat effect especially
cathine. At the peripheral level, cathine has the same
sympathomimetic effect as cathinone. However, as pointed
out, cathine could not wholly account for the CNS
stimulatory effect of fresh khat. First, dry khat leaves do
not have the same stimulatory potency as fresh leaves
though the cathine content is unchanged. Second, the
preference by the khat users for fresh khat rather than old
or aged khat suggested that there was something present in
fresh leaves which is absent in the old or aged khat. As the
cathinone content in fresh leaves decreases rapidly, and
from the preference of the user for fresh leaves, it appears
that khat user is seeking the effects of cathinone.
Furthermore, the lipophilicity of cathinone is greater than
cathine which would favour its penetration into the CNS
compared to cathine. Thus it would seem that the CNS
stimulation of khat is mostly due to cathinone, while the
peripheral effects are due equally to the action of cathinone
and cathine.
MECHANISM OF ACTION OF CATHINONE
A useful scientific approach to determine if cathinone
is responsible for the khat effects is to elucidate its mechanism
of action and compare that with the action of other known
ACTIVE INGREDIENT OF KHAT
The identity of the active ingredient of khat took sometime
to establish. In 1930, Wolfes(10) found the presence of an
alkaloid, norpseudoephedrine (cathine), in khat leaves
and up to the 1960s this was considered to be the main
active ingredient responsible for the effects of khat.
However, the amount of cathine in the leaves was
insufficient, accounting for only about ten per cent  of the
CNS stimulation observed(11) and the presence of another
compound was suspected. The United Nations Narcotics
Laboratory initiated further investigations into the
constituents of khat leaves. Fresh and freeze-dried material
obtained from Yemen, Kenya and Madagascar were
analysed and the presence of a keto analogue of cathine
termed cathinone was identified in 1975 (12). Cathinone
was found to be a labile substance present mainly in young
fresh leaves(13) and its concentration declined rapidly
within days after the leaves were removed from the khat
tree. The cathinone content was found to vary (0.9-3.3%)
according to the country of origin, with khat from Kenya
having the highest cathinone content (14). The molecular
structure of cathinone was found to be similar to
amphetamine (Figure 1). Besides the khatamine or
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psychostimulants such as amphetamine or cocaine. As the
structure of cathinone is similar to amphetamine, and khat
produces an amphetamine-like effect, most of the
investigations have looked at whether the mechanism of
CNS action is similar for the two compounds.
Effects of amphetamine are mediated through the release
of neurotransmitters at the cathecholaminergic synapses,
especially at the dopaminergic and serotinergic synapses.
Kalix(7,17) found cathinone stimulated release of
radioactive label from several rat brain regions (nucleus
accumbens, striatum and caudate nucleus) prelabelled
with 3H-dopamine. These regions are involved in the
amphetamine induced hypermotility, a behaviour also
observed with cathinone.
Like amphetamine, cathinone has also been found to
stimulate release of radioactive label from rat striatal
tissue prelabelled with 3H-serotonin. However, compared
to amphetamine, cathinone is a third-fold less potent than
amphetamine in causing this release(7). Interestingly, the
affinity for serotonin receptors by cathinone was found to
be about four times higher than amphetamine(18). This
finding along with that of Babayai et al(19) suggested that
activation of the serotonin pathways may have an important
role in action of cathinone compared to amphetamine.
BEHAVIOURAL EFFECTS OF CATHINONE
Cathinone has been shown to maintain drug-seeking
behaviour in rats habituated to amphetamine and monkeys
trained to lever press for cocaine injection(20,21). This
indicates that cathinone effects and sites of action have
similarity to those of amphetamine and cocaine. Likewise,
rats injected with cathinone display the same stereotypical
behaviour and hyperlocomotion observed with
amphetamines(22). In a further investigation of cathinone
induced hyperlocomotion, Calcagnetti and Schechter(22)
found that the effect could be produced by injection of
cathinone into the third ventricle and the nucleus accumbens
region of the brain but not in the substantia nigra. This is
in contrast to amphetamine studies which show that
substantia nigra is involved in amphetamine mediated
hyperlocomotion.
CONDITIONED PLACE PREFERENCE
A useful experimental paradigm widely used to assess
motivational properties of drugs of abuse is conditioned
place preference. In this approach, the animal learns to
associate a particular environment with a drug induced
state and another environment with a drug free state.
Depending on the effect of the drug, the animal may prefer
the environment associated with the drug induced state or
have an aversion to it. Drugs that are rewarding or
pleasurable will motivate the animal to prefer the drug
associated environment while drugs that cause discomfort
will have the opposite effect. With this experimental
paradigm, many drugs like amphetamines and
benzodiazepines abused in humans produce place
preference in laboratory animals(24,25). Cathinone also
produces place preference in rats both with peripheral and
central administration(26) which is inhibited by dopamine
antagonists(27). As motivational and reward state is
associated with activation of the dopaminergic neuronal
system, the place preference produced indicates that, like
amphetamine and cocaine, cathinone effects are due to an
increase in the dopamine levels in the brain.
STATUS OF KHAT AND CATHINONE
Depending on the country, the status of khat and
cathinone varies. In most countries of eastern African and
Arabian Peninsula, khat is freely and legally available. In
the USA, khat is classified as a Schedule IV substance and
cathinone classified as a Schedule I substance by the Drug
Enforcement Agency. The United Nation (UN) lists
cathinone in the Schedule 1 of the UN Convention on
Psychotropic Substances.
TREATMENT OF KHAT ADDICTION
There are very few reports of treatment of khat addition.
Gannini et al(28) reported two cases of khat dependency
which they treated with bromocriptine and desipramine
using a protocol developed for cocaine addiction.
NEW DEVELOPMENTS
Since 1991, methcathinone, a derivative of cathinone,
has emerged as a new street drug and cheap substitute for
methamphetamine in the US. Effects of short term
intoxication are similar to crack cocaine or
methamphetamine and anecdotal reports from patients in
treatment facilities in the US suggest that methcathinone
is highly addictive. Data from Russia, where methcathinone
abuse has been reported since the 1960’s, indicate that
many methcathinone addicts suffer permanent brain
damage and exhibit Parkinsoniam-like symptoms.
Methcathinone is currently on the US Schedule I controlled
substances list(29).
In conclusion, khat has a stimulatory and euphorogenic
effect in the user. Recent work has lead to the identification
of the main active ingredient of khat - a liable alkaloid,
cathinone, which appears to be primarily responsible for
the effects of khat on the user. A number of studies indicate
that the mechanism of action of cathinone is similar to that
of amphetamine and involves an increase in dopamine
levels in the brain. As most experimental investigations on
khat and cathinone have been short term acute studies,
there is a lack of important information on the long term
effects of khat use, in particular, whether it has the
neurotoxic potential.
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